The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Adrian M. Senderowicz

Radiation Biology Branch

National Cancer Institute

National Institutes of Health

Bldg. 10

USA

[email]@helix.nih.gov

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Radiation Biology Branch, National Cancer Institute, National Institutes of Health, Bldg. 10, USA. 2005
  • Oral & Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, USA. 2002 - 2004
  • Developmental Therapeutics Program Clinical Trials Unit, Medicine Branch, Biostatistics and Data Management Section, National Cancer Institute, USA. 1998 - 2000
  • DTP Clinical Trials Unit, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis. National Cancer Institute, Bethesda, USA. 1999

References

  1. Inhibitors of cyclin-dependent kinase modulators for cancer therapy. Senderowicz, A.M. Prog. Drug. Res (2005) [Pubmed]
  2. Targeting cell cycle and apoptosis for the treatment of human malignancies. Senderowicz, A.M. Curr. Opin. Cell Biol. (2004) [Pubmed]
  3. Novel small molecule cyclin-dependent kinases modulators in human clinical trials. Senderowicz, A.M. Cancer Biol. Ther. (2003) [Pubmed]
  4. Small-molecule cyclin-dependent kinase modulators. Senderowicz, A.M. Oncogene (2003) [Pubmed]
  5. Cell cycle modulators for the treatment of lung malignancies. Senderowicz, A.M. Clin. Lung. Cancer (2003) [Pubmed]
  6. Role of cell cycle control and cyclin-dependent kinases in breast cancer. Senderowicz, A.M. Breast. Dis (2002) [Pubmed]
  7. Preclinical and clinical development of cyclin-dependent kinase modulators. Senderowicz, A.M., Sausville, E.A. J. Natl. Cancer Inst. (2000) [Pubmed]
  8. Flavopiridol: the first cyclin-dependent kinase inhibitor in human clinical trials. Senderowicz, A.M. Invest. New. Drugs (1999) [Pubmed]
  9. Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms. Senderowicz, A.M., Headlee, D., Stinson, S.F., Lush, R.M., Kalil, N., Villalba, L., Hill, K., Steinberg, S.M., Figg, W.D., Tompkins, A., Arbuck, S.G., Sausville, E.A. J. Clin. Oncol. (1998) [Pubmed]
 
WikiGenes - Universities